Flower Mound Center for Plastic Surgery
Plastic Surgery
Dr. Jeremy D. Sanderson, MD
|
|
Give Review
Jeremy Sanderson is an expert in the field of Plastic Surgery. He studied medicine at University of Nebraska Medical Center. University of Nebraska Medical Center is one of the top medical schools in the US. University of Nebraska Medical Center has a rank of 60 in research and a 4 in primary care Jeremy Sanderson is a published MD as well. He has 56 publications published. The latest was: Distinguishing orofacial granulomatosis from crohn's disease: Two separate disease entities? He is registered with Medicare and accepts Medicare payments.
Publications
- Distinguishing oroFacial granulomatosis from crohn's disease: Two separate disease entities?
- Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's Disease.
- Probiotic and prebiotic use in patients with inflammatory bowel Disease: a case-control study.
- The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea.
- Helicobacter hypothesis for idiopathic parkinsonism: before and beyond.
- Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment.
- Mycobacterium avium subspecies paratuberculosis Infection in cases of irritable bowel syndrome and comparison with Crohn's disease and Johne's disease: common neural a...
- Improvement in oroFacial granulomatosis on a cinnamon- and benzoate-free diet.
- Genetic variation in the MTHFR gene influences thiopurine methyltransferase activity.
- Biases in Ig lambda light chain rearrangements in human intestinal plasma cells.
- High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine...
- Pharmacogenomics in the treatment of inflammatory bowel Disease.
- Genome-wide association study of CNVs in 16,000 cases of eight common Diseases and 3,000 shared controls.
- The contribution of deleterious DPYD gene sequence variants to fluoropyrimidine toxicity in British Cancer patients.
- Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region.
- Hyperbaric oxygen as a treatment for malabsorption in a radiation-damaged short bowel.
- Bone density improves with Disease remission in patients with inflammatory bowel Disease.
- Experience with the use of low-dose methotrexate for inflammatory bowel Disease.
- Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase).
- Subepithelial dendritic B cells in oroFacial granulomatosis.
- Further experience with the use of 6-thioguanine in patients with Crohn's Disease.
- Oro-Facial granulomatosis: Crohn's disease or a new inflammatory bowel disease?
- Diverse effects of the CARD15 and IBD5 loci on clinical phenotype in 630 patients with Crohn''s Disease.
- Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and inflammatory bowel Disease and their effects on Disease behavior: a case-control ...
- Investigation of association of the DLG5 gene with phenotypes of inflammatory bowel Disease in the British population.
- Selective white cell apheresis reduces relapse rates in patients with IBD at significant risk of clinical relapse.
- Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy?
- The contribution of NOD2 gene mutations to the risk and site of Disease in inflammatory bowel Disease.
- Genetic determinants of the thiopurine methyltransferase intermediate activity phenotype in British Asians and Caucasians.
- Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.
- A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's Disease and is independent of CARD15 and IBD5.
- Trial Protocol: Communicating DNA-based risk assessments for Crohn''s Disease: a randomised controlled trial assessing impact upon stopping smoking.
- Recruiting first-degree relatives for prevention research: a comparison of clinician and proband-led methods of contact in Crohn''s Disease.
- Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn''s Disease.
- Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn Disease.
- Direct or indirect association in a complex Disease: the role of SLC22A4 and SLC22A5 functional variants in Crohn Disease.
- Mutation, selection, and evolution of the Crohn Disease susceptibility gene CARD15.
- The ITPA c.94C>A and g.IVS2+21A>C sequence variants contribute to missplicing of the ITPA gene.
- Association of DLG5 R30Q variant with inflammatory bowel Disease.
- Difficulties and possibilities with thiopurine therapy in inflammatory bowel Disease--proceedings of the first Thiopurine Task Force meeting.
- Experience with anti-TNF-α therapy for oroFacial granulomatosis.
- Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency.
- Does the occurrence of certain rare Cancers indicate an inherited Cancer susceptibility?
- Low back pain, sacroiliitis, and the relationship with HLA-B27 in Crohn''s Disease.
- Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's Disease susceptibility loci.
- Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn''s Disease susceptibility.
- Independent and population-specific association of risk variants at the IRGM locus with Crohn''s Disease.
- Investigation of Crohn''s Disease risk loci in ulcerative colitis further defines their molecular relationship.
- Genetic variation in myosin IXB is associated with ulcerative colitis.
- Combined evidence from three large British Association studies rejects TUCAN/CARD8 as an IBD susceptibility gene.
- Incidence of adverse reactions to azathioprine in patients with Crohn''s Disease.
- IL23R variation determines susceptibility but not Disease phenotype in inflammatory bowel Disease.
- Association scan of 14,500 nonsynonymous SNPs in four Diseases identifies autoimmunity variants.
- A 22 year old man with persistent regurgitation and vomiting: case outcome.
- Laryngeal complications after lipoinjection for vocal fold augmentation.
Schools
Univ Of Tx Sch Of Med At San Antonio
University of Tennessee Memphis College of Medicine amp Surgery
University of Texas Medical School At San Antonio
University of Nebraska College of Medicine
Texas State University
Procedures Preformed
- Abdominoplasty
- Ablation or Excision of Nasal Turbinates
- Adjacent Tissue Transfer
- Antrostomy and Antrotomy (Sinus Surgery)
- View All
Conditions Treated
- Acoustic Neuroma
- Acute Laryngitis
- Acute Sinusitis
- Acute Tonsillitis
- View All
Doctors Specialties
- Ear, Nose, and Throat
- Plastic Surgery
Accepted Insurances
Education
-
University of Nebraska Medical Center -
University of Tennessee -
University of Texas Medical School
Drug Facts
| NPI NUMBER | 1679792048 | |
| NPPES Provider LastName | SANDERSON | |
| NPPES Provider FirstName | JEREMY | |
| NPPES Provider ZIPCode | 750281712 | |
| NPPES Provider State | TX | |
| Specialty Description | Plastic and Reconstructive Surgery | |
| Total Claim Count | 170.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 23.0 | |
| Percent Opioid Claims | 13.53 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1679792048 |
| Last Name Of The Provider | SANDERSON |
| First Name Of The Provider | JEREMY |
| View All |
Similar Doctors
|
Dr. Harry D. Galoob, MD
 This Doctor is OpenDoctor Recommended.
|